170 related articles for article (PubMed ID: 15300149)
1. Novel therapeutics in the treatment of bladder cancer.
Shah JB; McKiernan JM
Curr Opin Urol; 2004 Sep; 14(5):287-93. PubMed ID: 15300149
[TBL] [Abstract][Full Text] [Related]
2. New treatments for superficial bladder cancer.
Shah JB; Badalato GM; McKiernan JM
Curr Oncol Rep; 2006 May; 8(3):201-5. PubMed ID: 16618384
[TBL] [Abstract][Full Text] [Related]
3. [Innovations in superficial bladder cancer treatments].
Racioppi M; Volpe A; Falabella R; Cappa E; D'Agostino D; Pinto F; Bassi PF
Urologia; 2007; 74(3):133-8. PubMed ID: 21086390
[TBL] [Abstract][Full Text] [Related]
4. Bladder cancer.
Gwynn ES; Clark PE
Curr Opin Oncol; 2006 May; 18(3):277-83. PubMed ID: 16552241
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis and management of superficial bladder cancer.
Amling CL
Curr Probl Cancer; 2001; 25(4):219-78. PubMed ID: 11514784
[TBL] [Abstract][Full Text] [Related]
6. BCG and the treatment of superficial bladder cancer.
Moss JT; Kadmon D
DICP; 1991 Dec; 25(12):1355-67. PubMed ID: 1815434
[TBL] [Abstract][Full Text] [Related]
7. Superficial and muscle-invasive bladder cancer: principles of management for outcomes assessments.
Parekh DJ; Bochner BH; Dalbagni G
J Clin Oncol; 2006 Dec; 24(35):5519-27. PubMed ID: 17158537
[TBL] [Abstract][Full Text] [Related]
8. [Innovative treatments of non muscle invasive bladder cancer].
Racioppi M; D'Agostino D; Pugliese D; Ragonese M; Di Gianfrancesco L; Bassi P
Urologia; 2013; 80(2):120-6. PubMed ID: 23852929
[TBL] [Abstract][Full Text] [Related]
9. The importance of transurethral resection of bladder tumor in the management of nonmuscle invasive bladder cancer: a systematic review of novel technologies.
Richards KA; Smith ND; Steinberg GD
J Urol; 2014 Jun; 191(6):1655-64. PubMed ID: 24518761
[TBL] [Abstract][Full Text] [Related]
10. Bladder cancer: overview and management. Part 2: muscle-invasive and metastatic bladder cancer.
Anderson B
Br J Nurs; 2018 Oct; 27(18):S8-S20. PubMed ID: 30281356
[TBL] [Abstract][Full Text] [Related]
11. [Intravesical adjuvant chemotherapy for superficial bladder cancer -- results of a survey in Saxony].
Steinbach F; Schuster F
Aktuelle Urol; 2005 Aug; 36(4):337-41. PubMed ID: 16110407
[TBL] [Abstract][Full Text] [Related]
12. Treatment of superficial bladder tumors: achievements and needs. The EORTC Genitourinary Group.
Kurth KH; Bouffioux C; Sylvester R; van der Meijden AP; Oosterlinck W; Brausi M
Eur Urol; 2000; 37 Suppl 3():1-9. PubMed ID: 10828681
[TBL] [Abstract][Full Text] [Related]
13. Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association.
Kikuchi E; Fujimoto H; Mizutani Y; Okajima E; Koga H; Hinotsu S; Shinohara N; Oya M; Miki T;
Int J Urol; 2009 Mar; 16(3):279-86. PubMed ID: 19207609
[TBL] [Abstract][Full Text] [Related]
14. Intravesical therapy for bladder cancer.
Williams SK; Hoenig DM; Ghavamian R; Soloway M
Expert Opin Pharmacother; 2010 Apr; 11(6):947-58. PubMed ID: 20205607
[TBL] [Abstract][Full Text] [Related]
15. Can re-cTURBT be useful in pT1HG disease as a risk indicator of recurrence and progression? A single centre experience.
Giulianelli R; Gentile BC; Mirabile G; Albanesi L; Tariciotti P; Rizzo G; Buscarini M; Vermiglio M
Arch Ital Urol Androl; 2017 Dec; 89(4):272-276. PubMed ID: 29473376
[TBL] [Abstract][Full Text] [Related]
16. Repeated transurethral resection and intravesical BCG for extensive superficial bladder tumors.
Ozen H; Ekici S; Uygur MC; Akbal C; Sahin A
J Endourol; 2001 Oct; 15(8):863-7. PubMed ID: 11724131
[TBL] [Abstract][Full Text] [Related]
17. [Value of European Organisation for Research and Treatment of Cancer score system for predication of immediate postoperative intravesical instillation of pirarubicin after transurethral resection of non-muscle invasive bladder cancer].
Ding XL; Yang DL; Yan RP; Li ZP; Ye CW; He J; Yu L; He SC; Li HD
Zhonghua Zhong Liu Za Zhi; 2018 Apr; 40(4):308-312. PubMed ID: 29730921
[No Abstract] [Full Text] [Related]
18. Results of a prospective randomized study assessing the efficacy of fluorescent cystoscopy-assisted transurethral resection and single instillation of doxorubicin in patients with non-muscle-invasive bladder cancer.
Rolevich AI; Zhegalik AG; Mokhort AA; Minich AA; Vasilevich VY; Polyakov SL; Krasny SA; Sukonko OG
World J Urol; 2017 May; 35(5):745-752. PubMed ID: 27604374
[TBL] [Abstract][Full Text] [Related]
19. Intravesical and alternative bladder-preservation therapies in the management of non-muscle-invasive bladder cancer unresponsive to bacillus Calmette-Guérin.
Steinberg RL; Thomas LJ; Nepple KG
Urol Oncol; 2016 Jun; 34(6):279-89. PubMed ID: 26777259
[TBL] [Abstract][Full Text] [Related]
20. Intravesical therapy of superficial bladder cancer.
Melekos MD; Moutzouris GD
Curr Pharm Des; 2000 Feb; 6(3):345-59. PubMed ID: 10637383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
